Featured Company

Small Cap IR Initiates Coverage of Can-Fite Biopharma: Newly Discovered Late Clinical Stage BioPharma Vendor with Potentially Revolutionary Discoveries

Thank You for Joining the most Reliable Source for Balanced Research Reports on Current Market Trends.

Small Cap IR was the first firm to notify its members of CANF on 11-18-2014 with a full due diligence report before market open.

Get more winning stock picks from the most discerning group in the business right here.

Mid, Small and Micro Cap Stock Picks at One Place.

  • We alert FDA approval dates

  • Earnings watch alerts

  • Undervalued Micro-Caps

  • Full Reports Straight from the Analyst on Small, Mid and Micro Caps

  • Momentum plays

  • Chart Plays

We cater to the discerning trader, expect only the best

When we find a stock pick that meets or exceeds our criteria to qualify as an Alert, we will send a detailed report to you describing the reasons why we have chosen this stock.

We are the real deal when it comes to picking small and micro-cap stocks based on solid technical analysis’ and good ol’ fashion due diligence. We are not like the rest, so pay attention and do not forget to join our SMS/text alert service for free.

Send text to 25827 with keyword “SmallCapIR”

CANF Investor Update Written by Michael Anderegg,

Chartered Financial Analyst

Experienced investment professional specializing in financial markets research with significant technical and fundamental competencies.  Comprehensive analytical framework incorporates time cycle and multi-timeframe trend analysis to cover a wide variety of instruments and market conditions.

Published November 19, 2014

Use the PDF Icon provided below to get the full report on CANF.